XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Equity | 6 Months Ended
--- | ---
Jan. 31, 2018
Equity [Abstract] |
Equity | Note 6— Equity Changes in the components of equity were as follows:
|  | Six Months Ended January 31, 2018 |
|  | Attributable to IDT Corporation |  |  | Noncontrolling Interests |  |  | Total |
|  | (in thousands) |
Balance, July 31, 2017 |  | $ | 145,734 |  |  | $ | 8,823 |  |  | $ | 154,557 |
Dividends declared ($0.38 per share) |  |  | (9,440 | ) |  |  | — |  |  |  | (9,440 | )
Restricted Class B common stock purchased from employees |  |  | (61 | ) |  |  | — |  |  |  | (61 | )
Transfer of right to receive equity to Howard S. Jonas |  |  | — |  |  |  | (40 | ) |  |  | (40 | )
Consolidation of Lipomedix Pharmaceuticals Ltd. |  |  | — |  |  |  | 558 |  |  |  | 558 |
Distributions to noncontrolling interests |  |  | — |  |  |  | (717 | ) |  |  | (717 | )
Stock-based compensation |  |  | 1,797 |  |  |  | — |  |  |  | 1,797 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  | (576 | ) |  |  | 470 |  |  |  | (106 | )
Other comprehensive loss |  |  | (188 | ) |  |  | — |  |  |  | (188 | )
Comprehensive income |  |  | (764 | ) |  |  | 470 |  |  |  | (294 | )
Balance, January 31, 2018 |  | $ | 137,266 |  |  | $ | 9,094 |  |  | $ | 146,360 |
Dividend Payments In the six months ended January 31, 2018, the Company paid cash dividends of $0.38 per share on its Class A common stock and Class B common stock, or $9.4 million in total. In the six months ended October 31, 2016, the Company paid cash dividends of $0.38 per share on its Class A common stock and Class B common stock, or $8.8 million in total. On March 5, 2018, the Company’s Board of Directors declared a dividend of $0.09 per share for the second quarter of fiscal 2018 to holders of the Company’s Class A common stock and Class B common stock. The dividend will be paid on or about March 23, 2018 to stockholders of record as of the close of business on March 19, 2018. Stock Repurchases The Company has a stock repurchase program for the repurchase of up to an aggregate of 8.0 million shares of the Company’s Class B common stock. There were no repurchases under the program in the six months ended January 31, 2018 or 2017. At January 31, 2018, 8.0 million shares remained available for repurchase under the stock repurchase program. In the six months ended January 31, 2018 and 2017, the Company paid $0.1 million and $1.8 million, respectively, to repurchase 5,170 shares and 94,338 shares, respectively, of Class B common stock that were tendered by employees of the Company to satisfy the employees’ tax withholding obligations in connection with the lapsing of restrictions on awards of restricted stock. Such shares were repurchased by the Company based on their fair market value on the trading day immediately prior to the vesting date. 2015 Stock Option and Incentive Plan On December 14, 2017, the Company’s stockholders approved an amendment to the Company’s 2015 Stock Option and Incentive Plan to increase the number of shares of the Company’s Class B common stock available for the grant of awards thereunder by an additional 0.3 million shares. In the six months ended January 31, 2017, the Company received proceeds from the exercise of its stock options of $0.8 million. There were no stock option exercises in the six months ended January 31, 2018. In the six months ended January 31, 2017, the Company issued 73,471 shares of its Class B common stock for the stock option exercises.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration